<!DOCTYPE html>
<!--
    Licensed to the Apache Software Foundation (ASF) under one
    or more contributor license agreements.  See the NOTICE file
    distributed with this work for additional information
    regarding copyright ownership.  The ASF licenses this file
    to you under the Apache License, Version 2.0 (the
    "License"); you may not use this file except in compliance
    with the License.  You may obtain a copy of the License at

    http://www.apache.org/licenses/LICENSE-2.0

    Unless required by applicable law or agreed to in writing,
    software distributed under the License is distributed on an
    "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY
     KIND, either express or implied.  See the License for the
    specific language governing permissions and limitations
    under the License.
-->
<html>
<head>
    <meta charset="utf-8" />
    <meta name="format-detection" content="telephone=no" />
    <!-- WARNING: for iOS 7, remove the width=device-width and height=device-height attributes. See https://issues.apache.org/jira/browse/CB-4323 -->
    <meta name="viewport" content="user-scalable=no, initial-scale=1, maximum-scale=1, minimum-scale=1, width=device-width, height=device-height, target-densitydpi=device-dpi" />
    <link rel="stylesheet" type="text/css" href="css/index.css" />
    <link rel="stylesheet" type="text/css" href="css/jquery.mobile-1.4.0.css" />  
    <script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
    <script type="text/javascript" src="js/jquery.mobile-1.4.0.js"></script>
    <script type="text/javascript" src="phonegap.js"></script>
    <script type="text/javascript" src="js/index.js"></script>

    <script type="text/javascript">
    landing.initialize();
    </script>
    <script type="text/javascript">

            </script> 

            <title>IV to Oral Switch</title>
        </head>
        <body>
            <div data-role="page" data-theme="a" id="Page1">

                <div data-role="header" data-theme="c">
                    <a data-rel="back" data-role="button" class="ui-btn-left" data-transition="flip" data-icon="back"> Back </a>
                    <a href="info.html" data-role="button" class="ui-btn-right" data-transition="flip" data-icon="info"> Info </a>
                    <h2> IV to Oral Switch</h2>
                </div>

                <div data-role="content" data-theme="c" id="Page1_Content">
                    <img src="img/iv2oral.png" width=""></img>
                  <div class="considerations">
                    <div data-role="collapsible-set">

        <div data-role="collapsible" data-mini="true" data-collapsed-icon="arrow-r" data-expanded-icon="arrow-d" data-iconpos="right" data-theme="d" data-content-theme="d">
            <h3>C.O.M.S Box 1</h3>
                    <div class="infotext">
                  <hr>
                  <!-- Title -->
                  <span style="background-color:#A0A0A0"> <b> <u> Considerations for IV to oral switch </b> </u> </span> <br>
                  <!-- Body -->
                  <b> <u> C.O.M.S </b> </u> <br>
                  <b>C  &nbsp; C</b>linical improvement<br><br>
                  <b>O  &nbsp; O</b>ral route not comprimised<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Vomiting<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;NPO<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Unconscious<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Swallowing Problems<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Severe diarrhoea<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Malabsorptive disorder<br>
                  (if NG/PEG, please consult antimicrobial pharmacist).<br><br>
                  <b>M &nbsp; M</b>arkers showing a trend towards normal <br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Apyrexial: <b>Temp &gt;35.5 and &lt;38</b> for 24hrs<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus <i>not more than one of the following:</i><br>
                  <b>
                  •&nbsp;&nbsp;HR &gt;90beats/min<br>
                  •&nbsp;&nbsp;Respiratory Rate &gt;20breaths/min<br>
                  •&nbsp;&nbsp;BP unstable<br>
                  •&nbsp;&nbsp;WCC &lt;4 OR &gt;12</b> (if abnormal, a trend towards normal range and without neutropenia is acceptable)<br><br>
                  <b>S &nbsp; S</b>pecific indication/deep-seated infection<br>
                  <b><i>Specific indications requiring prolonged IV;</i></b><br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;<i>Staph. aureus or Pseudomonas aeruginosa</i> bacteraemia. <br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Severe necrotising soft tissue infections.<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Severe infections during chemotherapy related neutropenia<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Infected implants/Prostheses.<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Meningitis/Encephalitis.<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Intracranial abscesses<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Mediastinitis<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Infective Endocarditis<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Exacerbation of Cystic Fibrosis/Bronchiectasis<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Inadequately drained abscesses or empyema<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;Infections of foreign bodies e.g Central Line Infections<br>
                  <b><i>Examples of deep eared infections that may require an initial minimum 2 weeks of IV therapy;</i></b><br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Liver abscess<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Osteomyelitis<br>
                  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;Septic arthritis<br>
                  <hr> 
              </div>
          </div>

          <div data-role="collapsible" data-mini="true" data-collapsed-icon="arrow-r" data-expanded-icon="arrow-d" data-iconpos="right" data-theme="c" data-content-theme="c">
            <h3>Box 2</h3>
            <div class="infotext">
                <b>Box2 - some recommended empiric oral alternatives.<br>
                    N.B. Always check for allergy/interactions/microbiology results<br></b>
                    <div class="ui-grid-a">
                    <div class="ui-block-a"><b>IV Agent</b></div>
                    <div class="ui-block-b"><b>Oral Alternative</b></div>

                    <div class="ui-block-a">Amoxicillin 1g tds / qds</div>
                    <div class="ui-block-b">Amoxicillin 500mg-1g tds</div>
                    
                    <div class="ui-block-a">Benzylpenicillin 2.4g qds</div>
                    <div class="ui-block-b">Amoxicillin 500mg-1g tds</div>
                    
                    <div class="ui-block-a">Cefuroxime 750mg-1.5g tds</div>
                    <div class="ui-block-b">Co-amoxiclav 625mg tds Or Cefuroxime axetil 500mg bd</div>
                    
                    <div class="ui-block-a">Ciprofloxacin 400mg bd</div>
                    <div class="ui-block-b">Ciprofloxacin 500mg- 750mg bd</div>

                    <div class="ui-block-a">Clarithromycin 500mg bd</div>
                    <div class="ui-block-b">Clarithromycin 500mg bd</div>


                    <div class="ui-block-a">Clindamycin 600-900mg tds/ or 600mg qds</div>
                    <div class="ui-block-b">Clindamycin 150mg- 450mg qds</div>


                    <div class="ui-block-a">Co-amoxiclav 1.2g tds</div>
                    <div class="ui-block-b">Co-amoxiclav 625mg tds</div>

                    <div class="ui-block-a">Flucloxacillin 1-2g qds</div>
                    <div class="ui-block-b">Flucloxacillin 500mg-1g qds</div>

                    <div class="ui-block-a">Metronidazole 500mg tds</div>
                    <div class="ui-block-b">Metronidazole 400mg tds</div>

                    <div class="ui-block-a">Piperacillin/tazobactam, meropenem, vancomycin, teicoplanin, cefotaxime</div>
                    <div class="ui-block-b">Seek advice from microbiology</div>

                </div>
      </div>
  </div>
  </div>
  <div class="infotext">
        <b>Certain multi-resistant organisms often require treatment with agents that are only available as an intravenous form. Please seek advice from microbiology regarding length of treatment.</b>
        <br><br>
        <b>References</b><br>
        • IV to PO switch guideline. Nottingham University Hospitals, NHS trust. June 11. www.nuh.nhs.uk/antibiotics<br>
        • Switch to Oral therapy, Antibiotic Prescribing, British Society for Antimicrobial Chemotherapy. www.bsac.org.uk
    </div>

</div>
</div>

  <div data-role="footer" data-theme="c">
    <h2>(c) Darragh O'Connor </h2>
</div>


</div>



</body>
</html>
